|
|
 |
| |
|
|
Corporate
>
LifeCell's history
|
LifeCell Corporation was formed in 1986 to market a unique tissue preservation technology. Today, LifeCell develops and markets innovative tissue repair products for the reconstructive, orthopedic and urogynecologic biosurgery markets. The company’s mission is to advance the power of regenerative medicine by providing innovative products for tissue repair and replacement that deliver significant clinical and economic benefit.
AlloDerm® Regenerative Tissue Matrix, the flagship of LifeCell, was developed in 1994 as a graft for burn patients. Since that time, the remarkable versatility or AlloDerm® Tissue Matrix has led to its use in a host of other reconstructive applications, primarily in hernia, abdominal wall repair and breast reconstruction postmastectomy. AlloDerm® Tissue Matrix allows surgeons to restore many types of tissue damaged through injury or disease using the regenerative power of their patients’ own tissue.
Launched in 2008, Strattice™ Reconstructive Tissue Matrix supports tissue regeneration by allowing rapid revascularization, cell repopulation and white cell migration - just as leading surgeons have come to expect from LifeCell. In addition to these highly-valued benefits for challenging hernia repair and breast reconstruction, Strattice™ Tissue Matrix offers enhanced ease of use. It requires no rehydration, can be stored at room temperature and is available in large sizes. |
|
|
|
|
